Cargando…
Evaluating the levels of CSF and serum factors in ALS
OBJECTIVES: The aim of this study was to identify CSF and serum factors as biomarkers that may aid in distinguishing ALS patients from control subjects and predicting ALS progression as well as prognosis. METHODS: Serum and CSF samples from 105 patients with ALS and 56 control subjects were analyzed...
Autores principales: | Guo, Jie, Yang, Xuan, Gao, Lina, Zang, Dawei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346523/ https://www.ncbi.nlm.nih.gov/pubmed/28293476 http://dx.doi.org/10.1002/brb3.637 |
Ejemplares similares
-
Elevated Levels of IFN-γ in CSF and Serum of Patients with Amyotrophic Lateral Sclerosis
por: Liu, Juan, et al.
Publicado: (2015) -
Combination of serum and CSF neurofilament-light and neuroinflammatory biomarkers to evaluate ALS
por: Brodovitch, Alexandre, et al.
Publicado: (2021) -
Correlation of Serum M-CSF, CER, and TIMP-1 Levels with Liver Fibrosis in Viral Hepatitis
por: Yao, Hairong, et al.
Publicado: (2022) -
CSF p-tau as a potential cognition impairment biomarker in ALS
por: Gong, Zhongying, et al.
Publicado: (2022) -
Evaluation of Pre-Treatment Serum Levels of IL-7 and GM-CSF in Colorectal Cancer Patients
por: Taghipour Fard Ardekani, Mehdi, et al.
Publicado: (2014)